Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer’s Disease Detected Using Quantitative Electroencephalography
Open Access
- 26 May 2017
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 58 (4) , 1229-1244
Abstract
Background: Presenilin-1 (PSEN1) mutations are the most common cause of familial early onset Alzheimer’s disease (AD). The PSEN1 E280A (E280A) mutation has an autosomal dominant inheritance and is involved in the production of amyloid-β. The largest family group of carriers with E280A mutation is found in Antioquia, Colombia. The study of mutation carriers provides a unique opportunity to identify brain changes in stages previous to AD. Electroencephalography (EEG) is a low cost and minimally invasiveness technique that enables the following of brain changes in AD. Objective: To examine how previous reported differences in EEG for Theta and Alpha-2 rhythms in E280A subjects are related to specific regions in cortex and could be tracked across different ages. Methods: EEG signals were acquired during resting state from non-carriers and carriers, asymptomatic and symptomatic subjects from E280A kindred from Antioquia, Colombia. Independent component analysis (ICA) and inverse solution methods were used to locate brain regions related to differences in Theta and Alpha-2 bands. Results: ICA identified two components, mainly related to the Precuneus, where the differences in Theta and Alpha-2 exist simultaneously at asymptomatic and symptomatic stages. When the ratio between Theta and Alpha-2 is used, significant correlations exist with age and a composite cognitive scale. Conclusion: Theta and Alpha-2 rhythms are altered in E280A subjects. The alterations are possible to track at Precuneus regions using EEG, ICA, and inverse solution methods.Keywords
This publication has 81 references indexed in Scilit:
- Biomarkers in the diagnosis and management of Alzheimer’s diseaseMetabolism, 2015
- 2015: which new directions for Alzheimer's disease?Frontiers in Cellular Neuroscience, 2014
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention TrialsNeuron, 2014
- Ushering in the study and treatment of preclinical Alzheimer diseaseNature Reviews Neurology, 2013
- Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional studyThe Lancet Neurology, 2012
- Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriersJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Alzheimer’s Disease: A Clinical Practice-Oriented ReviewFrontiers in Neurology, 2012
- Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort studyThe Lancet Neurology, 2011
- Hippocampal hyperactivation in presymptomatic familial Alzheimer's diseaseAnnals of Neurology, 2010
- Neuropsychological stydy of familial Alzheimer's disease caused by mutation E280A in the presenilin 1 geneAmerican Journal of Alzheimer's Disease and Other Dementias®, 2003